Exhibit 99.1

 

 

 

 

 

 

VALENS SEMICONDUCTOR LTD.

 

CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

JUNE 30, 2023

 

 

 

 

 

 

 

 

 

VALENS SEMICONDUCTOR LTD.

 

CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

AS OF JUNE 30, 2023

 

CONTENTS

 

  Page
   
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)- IN U.S. DOLLARS ($):  
   
Balance sheets 3-4
Statements of operations 5
Statements of changes in shareholder’s equity 6
Statements of cash flows 7
Notes to consolidated financial statements 8-18

 

 

 

 

 

 

 

2

 

 

VALENS SEMICONDUCTOR LTD.

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

 

   June 30,
2023
   December 31,
2022
 
   U.S. dollars in thousands 
Assets        
         
CURRENT ASSETS:        
Cash and cash equivalents   21,410    20,024 
Short-term deposits   116,632    128,363 
Trade accounts receivable   16,057    11,514 
Prepaid expenses and other current assets   4,376    4,793 
Inventories   19,017    23,816 
TOTAL CURRENT ASSETS   177,492    188,510 
           
LONG-TERM ASSETS:          
Property and equipment, net   3,076    2,790 
Operating lease right-of-use assets   3,274    3,824 
Other assets   494    535 
TOTAL LONG-TERM ASSETS   6,844    7,149 
TOTAL ASSETS   184,336    195,659 

 

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements

 

3

 

 

VALENS SEMICONDUCTOR LTD.

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (continued)

 

   June 30,
2023
  

December 31,

2022

 
   U.S. dollars in thousands 
Liabilities and Shareholders’ Equity        

 

CURRENT LIABILITIES:

        
Trade accounts payable   3,896    10,651 
Accrued compensation   5,198    6,206 
Current maturities of operating leases liabilities   1,857    1,811 
Other current liabilities   5,775    6,121 
TOTAL CURRENT LIABILITIES   16,726    24,789 
           
LONG-TERM LIABILITIES:          
Forfeiture Shares, no par value: 1,006,250 shares authorized, issued and outstanding as of June 30, 2023, and December 31, 2022   222    1,751 
Non-current operating leases liabilities   989    1,624 
Other long-term liabilities   122    54 
TOTAL LONG-TERM LIABILITIES   1,333    3,429 
TOTAL LIABILITIES   18,059    28,218 
           
COMMITMENTS AND CONTINGENT LIABILITIES (note 5)        
 
 
           
SHAREHOLDERS’ EQUITY:          
Ordinary shares, no par value: 700,000,000 shares authorized as of June 30, 2023, and December 31, 2022; 101,843,066, and 98,876,266 (excluding 1,006,250 ordinary shares subject to forfeiture) shares issued and outstanding as of June 30, 2023, and December 31, 2022, respectively   49    49 
Additional paid-in capital   333,862    325,067 
Accumulated deficit   (167,634)   (157,675)
TOTAL SHAREHOLDERS’ EQUITY   166,277    167,441 
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY   184,336    195,659 

  

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements

 

4

 

 

VALENS SEMICONDUCTOR LTD.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

 

   Six months ended
June 30
   Three months ended
June 30
 
   2023   2022   2023   2022 
   U.S. dollars in thousands, except share and per share amounts 
                 
REVENUES   48,055    44,101    24,175    22,481 
COST OF REVENUES   (17,328)   (12,877)   (9,241)   (6,697)
GROSS PROFIT   30,727    31,224    14,934    15,784 
                     
OPERATING EXPENSES:                    
Research and development expenses   (26,121)   (29,031)   (12,161)   (14,904)
Sales and marketing expenses   (9,315)   (8,682)   (4,255)   (4,473)
General and administrative expenses   (7,533)   (8,641)   (3,701)   (4,340)
TOTAL OPERATING EXPENSES   (42,969)   (46,354)   (20,117)   (23,717)
OPERATING LOSS   (12,242)   (15,130)   (5,183)   (7,933)
Change in fair value of Forfeiture Shares   1,529    4,142    22    1,538 
Financial income (expenses), net   792    (3,675)   601    (3,560)
LOSS BEFORE INCOME TAXES   (9,921)   (14,663)   (4,560)   (9,955)
INCOME TAXES   (45)   (389)   (26)   (43)
LOSS AFTER INCOME TAXES   (9,966)   (15,052)   (4,586)   (9,998)
Equity in earnings of an investee   7    7    4    3 
NET LOSS   (9,959)   (15,045)   (4,582)   (9,995)

Basic and diluted net loss per ordinary share

   (0.10)   (0.15)   (0.05)   (0.10)
Weighted average number of shares used in computing net loss per ordinary share
   101,381,153    97,296,206    101,685,915    97,442,359 

 

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements

 

5

 

 

VALENS SEMICONDUCTOR LTD.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY (Unaudited)

 

   Six months ended June 30, 2023 
   Ordinary shares   Additional paid-in   Accumulated    
   Shares   Amount   capital   deficit   Total 
                     
Balance as of January 1, 2023   (*) 98,876,266    49    325,067    (157,675)   167,441 
Exercise of options and vesting of RSUs   2,966,800    
-
    986    
-
    986 
Stock-based compensation   -    
-
    7,809    
-
    7,809 
Net loss for the period   -    
-
    
-
    (9,959)   (9,959)
Balance as of June 30, 2023   (*) 101,843,066    49    333,862    (167,634)   166,277 

 

   Six months ended June 30, 2022 
   Ordinary shares   Additional paid-in   Accumulated     
   Shares   Amount   capital   deficit   Total 
                     
Balance as of January 1, 2022   (*) 97,122,405    49    312,156    (130,008)   182,197 
Exercise of options   542,264    
-
    150    
-
    150 
Stock-based compensation   -    
-
    5,908    
-
    5,908 
Net loss for the period   -    
-
    
-
    (15,045)   (15,045)
Balance as of June 30, 2022   (*) 97,664,669    49    318,214    (145,053)   173,210 

 

   Three months ended June 30, 2023 
   Ordinary shares   Additional paid-in   Accumulated     
   Shares   Amount   capital   deficit   Total 
                     
Balance as of April 1, 2023   (*) 101,465,926    49    329,817    (163,052)   166,814 
Exercise of options and vesting of RSUs   377,140    
-
    58    
-
    58 
Stock-based compensation   -    
-
    3,987    
-
    3,987 
Net loss for the period   -    
-
    
-
    (4,582)   (4,582)
Balance as of June 30, 2023   (*) 101,843,066    49    333,862    (167,634)   166,277 

 

   Three months ended June 30, 2022 
   Ordinary shares   Additional paid-in   Accumulated     
   Shares   Amount   capital   deficit   Total 
                     
Balance as of April 1, 2022   (*) 97,191,467    49    315,001    (135,058)   179,992 
Exercise of options   473,202    
-
    96    
-
    96 
Stock-based compensation   -    
-
    3,117    
-
    3,117 
Net loss for the period   -    
-
    
-
    (9,995)   (9,995)
Balance as of June 30, 2022   (*) 97,664,669    49    318,214    (145,053)   173,210 

 

(*)Excluding 1,006,250 Forfeiture Shares

 

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements

 

6

 

 

VALENS SEMICONDUCTOR LTD.

CONDENSED INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

 

   Six months ended
June 30
   Three months ended
June 30
 
   2023   2022   2023   2022 
   U.S. dollars in thousands 
                 
CASH FLOWS FROM OPERATING ACTIVITIES:                
Net loss for the period   (9,959)   (15,045)   (4,582)   (9,995)
Adjustments to reconcile net loss to net cash used in operating activities:                    
Income and expense items not involving cash flows:                    
Depreciation   793    667    414    347 
Stock-based compensation   7,809    5,908    3,987    3,117 
Exchange rate differences   2,273    4,972    1,021    4,501 
Interest on short-term deposits   (389)   (295)   177    (132)
Change in fair value of Forfeiture Shares   (1,529)   (4,142)   (22)   (1,538)
Reduction in the carrying amount of ROU assets   986    844    522    424 
Equity in earnings of investee, net of dividend received   7    7    4    3 
Changes in operating assets and liabilities:                    
Trade accounts receivable   (4,575)   (2,952)   (3,176)   166 
Prepaid expenses and other current assets   403    3,763    1,042    3,245 
Inventories   4,799    (7,996)   4,549    (4,852)
Other assets   34    183    (8)   83 
Trade accounts payable   (6,948)   2,779    (1,475)   1,691 
Accrued compensation   (1,008)   329    158    508 
Other current liabilities   (216)   (366)   (1,797)   (1,010)
Change in operating lease liabilities   (859)   (1,312)   (457)   (811)
Other long-term liabilities   68    2    1    2 
Net cash provided by (used in) operating activities   (8,311)   (12,654)   358    (4,251)
                     
CASH FLOWS FROM INVESTING ACTIVITIES:                    
Investment in short-term deposits   (109,153)   (31,340)   (68,428)   (13,088)
Maturities of short-term deposits   118,954    37,400    74,810    21,900 
Purchase of property and equipment   (919)   (424)   (777)   (244)
Net cash provided by investing activities   8,882    5,636    5,605    8,568 
                     
CASH FLOWS FROM FINANCING ACTIVITIES:                    
Exercise of stock options   986    150    58    96 
Net cash provided by financing activities   986    150    58    96 
                     
Effect of exchange rate changes on cash and cash equivalents   (171)   (3,346)   (100)   (2,830)
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS   1,386    (10,214)   5,921    1,583 
CASH AND CASH EQUIVALENTS AT THE BEGINNING OF THE PERIOD   20,024    56,791    15,489    44,994 
CASH AND CASH EQUIVALENTS AT THE END OF THE PERIOD   21,410    46,577    21,410    46,577 
                     
SUPPLEMENT DISCLOSURE OF CASH FLOW INFORMATION -                    
Cash paid for taxes   252    121    213    65 
                     
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:                    
Trade accounts payable on account on property and equipment   160    73    35    - 
Operating lease liabilities arising from obtaining operating right-of-use assets   436    350    152    104 

 

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements

 

7

 

 

VALENS SEMICONDUCTOR LTD.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

 

NOTE 1 - GENERAL:

 

Valens Semiconductor Ltd. (hereafter “Valens”, and together with its wholly owned subsidiaries, the “Company”), was incorporated in Israel in 2006.

 

As of September 30, 2021, the Company began trading on the New York Stock Exchange under the Symbol “VLN”.

 

Please also refer to Note 1(c) in the consolidated financial statement for the year ended December 31, 2022.

 

Valens is a leading provider of semiconductor products (chips), operates in the Audio-Video and Automotive industries, renowned for its Physical Layer (PHY) technology, enabling resilient high-speed connectivity over simple, low-cost infrastructure. Valens is the inventor of the HDBaseT Technology, which enables the converged delivery of ultra-high-definition digital video and audio, Ethernet, control signals, USB and power through a single cable. In the audio-video space, Valens’ HDBaseT technology enables plug-and-play digital connectivity between ultra-HD video sources and remote displays. In the automotive domain, Valens’ product offering includes both symmetric and asymmetric connectivity technology for high bandwidth transmission of native interfaces over a single low-cost wires and connectors. Valens’ advanced PHY technology for the auto industry provides the safety and resilience required to handle the noisy automotive environment, addressing the needs of Advanced Driver Assistance Systems (ADAS), Automotive Data Solutions (ADS), infotainment, telematics and backbone connectivity.

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:

 

a.Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial reporting.

 

Certain information and footnote disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. In our opinion, the information contained herein reflects all adjustments necessary for a fair statement of our results of operations, financial position, cash flows, and shareholders’ equity. All such adjustments are of a normal, recurring nature.

 

The results of operations for the six and three months ended June 30, 2023, shown in these financial statements are not necessarily indicative of the results to be expected for the full year ending December 31, 2023. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2022.

 

The carrying value of cash and cash equivalents, accounts receivables, deposits and accounts payable (included in the condensed consolidated balance sheets) approximates their fair value because of their generally short maturities.

 

There have been no material changes in our significant accounting policies as described in our consolidated financial statements for the year ended December 31, 2022, other than as stated below.

 

8

 

 

VALENS SEMICONDUCTOR LTD.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) (continued)

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued):

 

b.Accounts receivable, net

 

Trade accounts receivable are recorded at the invoiced amount and do not include finance charges. The Company performs ongoing credit evaluation of its customers and generally requires no collateral.

 

The Company’s accounts receivables accounting policy from January 1, 2023, following the adoption of the new CECL standard:

 

The Company estimates CECL on trade receivables at inception for estimated losses resulting from the inability of the Company’s customers to make required payments, based on estimated current expected credit losses. The allowance represents the current estimate of lifetime expected credit losses over the remaining duration of existing accounts receivable considering historical information, current market conditions and reasonable and supportable forecasts when appropriate. The estimate is a result of the Company’s ongoing evaluation of collectability, customer creditworthiness, historical levels of credit losses, and future expectations.

 

There were no write-offs of accounts receivable for the six and three months ended June 30, 2023, and 2022, respectively. There are no expected credit losses recorded as of June 30, 2023, and December 31, 2022.

 

The Company’s accounts receivables accounting policy until December 31, 2022, prior to the adoption of the new CECL standard:

 

The Company assesses the need for allowances for doubtful accounts for estimated losses resulting from the inability of its customers to make required payments by considering factors such as historical collection experience, credit quality, aging of the accounts receivable balances and current economic conditions that may affect a customer’s ability to pay.

 

c.New Accounting Pronouncements

 

Recently Adopted accounting Standards:

 

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments—Credit Losses (“ASC 326”): Measurement of Credit Losses on Financial Instruments to introduce a new model for recognizing credit losses on financial instruments based on estimated current expected credit losses, or CECL. Under the new standard, an entity is required to estimate CECL on trade receivables at inception, based on historical information, current conditions, and reasonable and supportable forecasts. The guidance is effective for the Company for annual periods beginning after December 15, 2022, including interim periods within those fiscal years. Early application is permitted. The Company adopted ASC 326 on January 1, 2023, and there was no material impact on the Company’s consolidated balance sheet and the consolidated statements of operations upon adoption.

 

9

 

 

VALENS SEMICONDUCTOR LTD.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) (continued)

 

NOTE 3 – INVENTORIES:

 

   June 30,
2023
   December 31,
2022
 
   U.S. dollars in thousands 
Work in process   8,434    9,870 
Finished goods   10,583    13,946 
    19,017    23,816 

 

Inventories write-downs amounted to $397 thousand and $0 thousand during the six months ended June 30, 2023, and 2022, respectively. Inventories write-downs amounted to $273 thousand and $0 thousand during the three months ended June 30, 2023, and 2022, respectively. Inventories write-downs are recorded in cost of revenues.

 

NOTE 4 - COMMITMENTS AND CONTINGENT LIABILITIES:

 

a.Noncancelable Purchase Obligations

 

The Company depends upon third party subcontractors for manufacturing of wafers, packaging and final tests. As of June 30, 2023, and December 31, 2022, the total value of open purchase orders for such manufacturing contractors was approximately $10,038 thousand and $19,418 thousand, respectively.

 

The Company has noncancelable purchase agreements for certain IP embedded in the Company products as well as certain agreement for the license of development tools used by the development team. As of June 30, 2023, and December 31, 2022, the value of non-paid amounts related to such agreements totaled to $1,502 thousand and $2,783 thousand, respectively.

 

b.Legal proceedings

 

As of June 30, 2023, and to date, the Company is not a party to, or subject to the provisions of any order, writ, injunction, judgment or decree of any court or governmental agency or instrumentality. There is no action, suit, proceeding or investigation by the Company currently pending or that the Company intends to initiate.

 

NOTE 5 - OTHER CURRENT LIABILITIES:

 

   June 30,
2023
   December 31,
2022
 
   U.S. dollars in thousands 
         
Accrued vacation   3,387    3,203 
Taxes payable   37    514 
Contract liabilities   32    175 
Accrued expenses- related party   142    142 
Other Accrued expenses   2,177    2,087 
    5,775    6,121 

 

The amounts of revenues that were included in the contract liabilities’ balance as of December 31, 2022 and December 31, 2021 and were recognized in the period of six months ended June 30, 2023, and June 30, 2022, were $175 and $0 respectively.

 

10

 

 

VALENS SEMICONDUCTOR LTD.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) (continued)

 

NOTE 6 - FORFEITURE SHARES:

 

a.On September 29, 2021 (the “Closing Date”, please refer to note 1c of the financial statements as of December 31, 2022), 1,006,250 Ordinary Shares that PTK sponsor received in respect of its PTK common stock, are subject to forfeiture if certain price targets for the Valens Ordinary Shares are not achieved within a certain period of time (of up to four years), after the Closing Date or if an M&A Transaction (as defined in the Merger Agreement Closing, please refer to note 1c of the financial statements as of December 31, 2022), does not occur at a certain minimum price.

 

The Company performed a Monte-Carlo simulation to calculate the fair value of such shares.

 

The fair value of the Forfeiture Shares was computed using the following key assumptions:

 

   June 30,
2023
   December 31,
2022
 
Stock price   2.53    5.37 
Expected term (years)   1.25-2.25    1.75-2.75 
Expected volatility   65.32%-68.22%   51.37%-53.53%
Risk-free interest rate   4.78%-5.27%   4.27%-4.49%

 

b.The table below sets forth a summary of the changes in the fair value of the Forfeiture Shares classified as Level 3:

 

   Six months ended
June 30,
2023
   Year
ended
December 31,
2022
 
   U.S. dollars in thousands 
Balance at beginning of period   1,751    4,658 
Changes in fair value   (1,529)   (2,907)
Balance at end of the period   222    1,751 

 

NOTE 7 - STOCK-BASED COMPENSATION:

 

Stock Options

 

As of June 30, 2023, and December 31, 2022, the number of ordinary shares included in the Company’s option plans totaled to 30,666,212 and 28,383,788, respectively.

 

1,086,311 out of the outstanding options that have not yet vested as of June 30, 2023, have acceleration mechanisms according to certain terms set forth in the grant agreements primarily in the case of an M&A Transaction which constitutes a Liquidation Event.

 

As of June 30, 2023, the unrecognized compensation costs related to those unvested stock options are $3,048 thousand, which are expected to be recognized over a weighted-average period of 1.4 years.

 

11

 

 

VALENS SEMICONDUCTOR LTD.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) (continued)

 

NOTE 7 - STOCK-BASED COMPENSATION (continued):

 

The following is a summary of the status of the Company’s share option plan as of June 30, 2023:

 

  

Six months ended

 
   June 30, 2023 
   Number of Options   Weighted-Average Exercise price 
Options outstanding as of December 31, 2022   13,948,149   $0.85 
Granted during the period   212,329   $4.97 
Exercised during the period   (1,865,217)  $0.53 
Expired during the period   (19,876)  $0.75 
Forfeited during the period   (28,837)  $2.85 
Options outstanding as of June 30, 2023   12,246,548   $0.96 
Options exercisable as of June 30, 2023   10,492,188   $0.86 

 

The following table summarizes information about stock options outstanding as of June 30, 2023:

 

Outstanding as of June 30, 2023   Exercisable as of June 30, 2023 
Range of exercise prices   Number outstanding   Weighted average remaining contractual term   Weighted average exercise price  

Aggregate intrinsic value
(U.S. dollars in thousands)

   Number Exercisable  

Weighted average remaining contractual term

   Weighted Average exercise price  

Aggregate intrinsic value
(U.S. dollars in thousands)

 
$0.15-$0.86    11,761,752    5.25   $0.67    20,598    10,292,067    4.97   $0.77    18,144 
$1.87    4,803    7.53   $1.87    3    3,353    7.53   $1.87    2 
$2.10    33,126    1.20   $2.10    14    33,126    1.20   $2.10    14 
$2.40    1,474    7.00   $2.40    -    -    -    -    - 
$4.99    200,183    6.55   $4.99    -    24,906    6.55   $4.99    - 
$5.36    140,000    6.00   $5.36    -    35,000    6.00   $5.36    
-
 
$7.58    99,610    5.55   $7.58    
-
    99,610    5.55   $7.58    
-
 
$9.07    5,600    5.46   $9.07    
-
    4,126    5.46   $9.07    
-
 

 

The calculated fair value of option grants was estimated using the Black-Scholes option-pricing model with the following assumptions:

 

   For the
Six months
ended
on June 30,
2023
   For the
six months
ended
on June 30,
2022
 
Expected term   3-5    4-6 
Expected volatility   48.35%-63.84%   46.73%-47.71%
Expected dividend rate   0%   0%
Risk-free rate   3.62%-4.21%   1.37%-3.00%

 

During the six months period ended on June 30, 2023, 212,329 options were granted to related parties (please refer to Note 11 for further information).

 

As of June 30, 2023, the unrecognized compensation costs related to unvested stock options was $5,985 thousand, which are expected to be recognized over a weighted-average period of 1.55 years.

 

The weighted-average fair value of the options that were granted during the period ended June 30, 2023 was $2.25 at the grant date.

 

12

 

 

VALENS SEMICONDUCTOR LTD.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) (continued)

 

NOTE 7 - STOCK-BASED COMPENSATION (continued):

 

The total intrinsic value of options exercised during the period of six months ended June 30, 2023 was $7,965 thousand.

 

The following table presents the classification of the stock options expenses for the periods indicated:

 

   Six months ended
June 30
   Three months ended
June 30
 
   2023   2022   2023   2022 
   U.S. dollars in thousands 
                 
Cost of revenue   96    114    46    60 
Research and development   631    907    309    456 
Sales and marketing   570    655    278    329 
General and administrative   1,350    1,404    671    715 
Total stock-based compensation   2,647    3,080    1,304    1,560 

 

Restricted Stock Units

 

The following is a summary of the status of the Company’s RSU’s as of June 30, 2023, as well as changes during the period of six months ended June 30, 2023:

 

   Number of
RSUs
   Weighted-Average
Grant Date
Fair Value
 
RSUs outstanding at the beginning of the year   3,779,716   $6.08 
Granted during the period   3,772,631   $5.17 
Vested during the period   (1,101,583)  $6.26 
Forfeited during the period   (130,311)  $5.56 
Outstanding at the end of the period   6,320,453   $5.52 
RSUs exercisable as of June 30, 2023   5,947,712   $5.52 

 

As of June 30, 2023, the unrecognized compensation cost related to unvested RSUs totaled to approximately $29,410 thousand and is expected to be expensed over a weighted-average recognition period of approximately 3.1 years.

 

During the six months ended on June 30, 2023, 490,529 RSU’s were granted to several related parties (please refer to Note 11 regarding Related Parties).

 

The following table presents the classification of RSU’s expenses for the periods indicated:

 

   Six months ended
June 30
   Three months ended
June 30
 
   2023   2022   2023   2022 
   U.S. dollars in thousands 
                 
Cost of revenue   288    155    151    84 
Research and development   2,779    1,467    1,462    809 
Sales and marketing   1,197    614    613    344 
General and administrative   898    592    457    320 
Total stock-based compensation-RSUs   5,162    2,828    2,683    1,557 

 

13

 

 

VALENS SEMICONDUCTOR LTD.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) (continued)

 

NOTE 8 - NET INCOME (LOSS) PER ORDINARY SHARE:

 

The following table sets forth the computation of basic and diluted net income (loss) per ordinary share for the periods indicated:

 

   Six months ended   Three months ended 
   June 30,
2023
   June 30,
2022
   June 30,
2023
   June 30,
2022
 
Basic net loss per ordinary share                
Numerator:                
Net loss   (9,959)   (15,045)   (4,582)   (9,995)
                     
Denominator:                    
Weighted average common shares – basic and diluted
   101,381,153    

97, 296,206

    101,685,915    97,442,359 
Basic and dilutive net loss per common share
   (0.10)   (0.15)   (0.05)   (0.10)

 

The following weighted-average shares of securities were not included in the computation of diluted net income (loss) per common share as their effect would have been anti-dilutive:

 

   Six months ended   Three months ended 
   June 30,
2023
   June 30,
2022
   June 30,
2023
   June 30,
2022
 
Options   13,097,348    15,378,561    12,315,780    15,300,870 
Restricted Stock Units   5,050,085    2,748,135    6,486,973    3,649,756 
Private Warrants   3,330,000    3,330,000    3,330,000    3,330,000 
Public Warrants   5,750,000    5,750,000    5,750,000    5,750,000 
Forfeiture Shares   1,006,250    1,006,250    1,006,250    1,006,250 

 

NOTE 9 - FINANCIAL INCOME (EXPENSES), NET:

 

   Six months ended
June 30
   Three months ended
June 30
 
   2023   2022   2023   2022 
   U.S. dollars in thousands 
                 
Foreign currency exchange differences   (2,273)   (3,865)   (1,021)   (3,554)
Interest income on short-term deposits   3,090    404    1,630    199 
Other   (25)   (214)   (8)   (205)
Total financial income (expenses), net   792    (3,675)   601    (3,560)

 

14

 

 

VALENS SEMICONDUCTOR LTD.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) (continued)

 

NOTE 10 - SEGMENT AND REVENUE BY GEOGRAPHY AND BY MAJOR CUSTOMER:

 

a.For the purpose of evaluating financial performance and allocating resources, the CODM reviews financial information presented on a consolidated basis accompanied by disaggregated information about revenues, gross profit and operating loss by the two identified reportable segments, to make decisions about resources to be allocated to the segments and assess their performance. Assets information is not provided to the CODM and is not being reviewed. Revenues and cost of goods sold are directly associated with the activities of a specific segment. Direct operating expenses, including general and administrative expenses, associated with the activities of a specific segment are charged to that segment. General and administrative expenses which cannot be attributed directly, are allocated evenly between segments. Other operating expenses are allocated to segments based on headcount ratio.

 

   Six months ended on June 30, 2023 
   Audio-Video   Automotive   Consolidated 
   U.S. dollars in thousands 
Revenues   31,828    16,227    48,055 
Gross profit   24,734    5,993    30,727 
Research and development expenses   11,094    15,027    26,121 
Sales and marketing expenses   4,009    5,306    9,315 
General and administrative expenses   3,756    3,777    7,533 
Segment operating profit (loss)   5,875    (18,117)   (12,242)
Change in fair value of Forfeiture Shares             1,529 
Financial expenses, net             792 
Loss before taxes on income             (9,921)
                
Depreciation expenses   352    441    793 
Stock-based compensation   3,287    4,522    7,809 

 

   Six months ended on June 30, 2022 
   Audio-Video   Automotive   Consolidated 
   U.S. dollars in thousands 
Revenues   35,067    9,034    44,101 
Gross profit   27,881    3,343    31,224 
Research and development expenses   11,392    17,639    29,031 
Sales and marketing expenses   3,695    4,987    8,682 
General and administrative expenses   4,244    4,397    8,641 
Segment operating profit (loss)   8,550    (23,680)   (15,130)
Change in fair value of Forfeiture Shares             4,142 
Financial expenses, net             (3,675)
Loss before taxes on income             (14,663)
                
Depreciation expenses   303    364    667 
Stock-based compensation   2,517    3,391    5,908 

 

15

 

 

VALENS SEMICONDUCTOR LTD.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) (continued)

 

NOTE 10 - SEGMENT AND REVENUE BY GEOGRAPHY AND BY MAJOR CUSTOMER (continued):

 

   Three months ended on June 30, 2023 
   Audio-Video   Automotive   Consolidated 
   U.S. dollars in thousands 
Revenues   15,469    8,706    24,175 
Gross profit   11,644    3,290    14,934 
Research and development expenses   4822    7,339    12,161 
Sales and marketing expenses   1,892    2,363    4,255 
General and administrative expenses   1,857    1,844    3,701 
Segment operating profit (loss)   3,072    (8,255)   (5,183)
Change in fair value of Forfeiture Shares             22 
Financial expenses, net             601 
Loss before taxes on income             (4,560)
                
Depreciation expenses   173    241    414 
Stock-based compensation   1,678    2,309    3,987 

 

   Three months ended on June 30, 2022 
   Audio-Video   Automotive   Consolidated 
   U.S. dollars in thousands 
Revenues   18,335    4,146    22,481 
Gross profit   14,414    1,370    15,784 
Research and development expenses   5,122    9,782    14,904 
Sales and marketing expenses   1,917    2,556    4,473 
General and administrative expenses   2,081    2,259    4,340 
Segment operating profit (loss)   5,294    (13,227)   (7,933)
Change in fair value of Forfeiture Shares             1,538 
Financial expenses, net             (3,560)
Loss before taxes on income             (9,955)
                
Depreciation expenses   161    186    347 
Stock-based compensation   1,326    1,791    3,117 

 

16

 

 

VALENS SEMICONDUCTOR LTD.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) (continued)

 

NOTE 10 - SEGMENT AND REVENUE BY GEOGRAPHY AND BY MAJOR CUSTOMER (continued):

 

b.Geographic Revenues

 

The following table shows revenue by geography, based on the customers’ “bill to” location:

 

   Six months ended
June 30
   Three months ended
June 30
 
   2023   2022   2023   2022 
   U.S. dollars in thousands 
                 
Israel   1,266    1,279    543    749 
China   4,755    5,339    2,332    2,533 
United States   3,441    7,238    1,981    3,681 
Hong Kong   4,134    7,286    2,383    3,965 
Hungary   13,013    6,399    6,955    2,486 
Japan   4,605    5,274    2,248    3,239 
Germany   5,637    2,807    2,989    965 
Taiwan   4,992    4,030    1,748    2,679 
Other   6,212    4,449    2,996    2,184 
    48,055    44,101    24,175    22,481 

 

c.Supplemental data - Major Customers:

 

The following tables summarize the significant customers’ (including distributors) accounts receivable and revenues as a percentage of total accounts receivable and total revenues, respectively:

 

   June 30,
2023
   December 31,
2022
 
Accounts Receivable  % of accounts receivable 
Customer A   30%   10%
Customer B   13%   26%
Customer C   0%   16%

 

   Six months ended
June 30,
   Three months ended
June 30,
 
   2023   2022   2023   2022 
Revenues  % of revenues   % of revenues 
Customer A   19%   10%   21%   10%
Customer B   11%   12%   11%   15%
Customer D   9%   11%   9%   14%
Customer E   8%   6%   6%   7%

 

17

 

 

VALENS SEMICONDUCTOR LTD.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) (continued)

 

NOTE 10 - SEGMENT AND REVENUE BY GEOGRAPHY AND BY MAJOR CUSTOMER (continued):

 

d.Long-lived assets by Geography:

 

   June 30,
2023
   December 31,
2022
 
   U.S. dollars in thousands 
Domestic (Israel)   5,459    5,827 
Taiwan   417    184 
China   206    225 
USA   154    217 
Singapore   98    124 
Other   16    37 
    6,350    6,614 

 

NOTE 11 - RELATED PARTY TRANSACTIONS

 

During the six months ended June 30, 2023, the Company granted 212,329 stock options, at a weighted average exercise price of $4.97 to several executive officers, and Board of Directors (“Board”) members of the Company. In addition, during the six months ended June 30, 2023 the Company granted 490,529 RSUs to several executive officers and Board members of the Company.

 

The fair value of the stock options that were granted during the six months ended June 30, 2023 is $438 thousand, which is expected to be recognized over a 1-4 years vesting period, and the fair value of the granted RSUs is $2,354 thousand, which is expected to be recognized over a 1-4-years vesting period.

 

 

 

 

 

 

 

 

 

 

18

 

0.05 0.10 0.10 0.15 101381153 101685915 97296206 97442359 97296206 97296206 101381153 101685915 97442359 0.05 0.10 0.10 0.15 false --12-31 Q2 2023-06-30 0001863006 0001863006 2023-01-01 2023-06-30 0001863006 2023-06-30 0001863006 2022-12-31 0001863006 2022-01-01 2022-06-30 0001863006 2023-04-01 2023-06-30 0001863006 2022-04-01 2022-06-30 0001863006 us-gaap:CommonStockMember 2022-12-31 0001863006 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001863006 us-gaap:RetainedEarningsMember 2022-12-31 0001863006 us-gaap:CommonStockMember 2023-01-01 2023-06-30 0001863006 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-06-30 0001863006 us-gaap:RetainedEarningsMember 2023-01-01 2023-06-30 0001863006 us-gaap:CommonStockMember 2023-06-30 0001863006 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001863006 us-gaap:RetainedEarningsMember 2023-06-30 0001863006 us-gaap:CommonStockMember 2021-12-31 0001863006 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001863006 us-gaap:RetainedEarningsMember 2021-12-31 0001863006 2021-12-31 0001863006 us-gaap:CommonStockMember 2022-01-01 2022-06-30 0001863006 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-06-30 0001863006 us-gaap:RetainedEarningsMember 2022-01-01 2022-06-30 0001863006 us-gaap:CommonStockMember 2022-06-30 0001863006 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001863006 us-gaap:RetainedEarningsMember 2022-06-30 0001863006 2022-06-30 0001863006 us-gaap:CommonStockMember 2023-03-31 0001863006 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001863006 us-gaap:RetainedEarningsMember 2023-03-31 0001863006 2023-03-31 0001863006 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001863006 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001863006 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001863006 us-gaap:CommonStockMember 2022-03-31 0001863006 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001863006 us-gaap:RetainedEarningsMember 2022-03-31 0001863006 2022-03-31 0001863006 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001863006 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001863006 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001863006 us-gaap:CostOfSalesMember 2023-06-30 0001863006 us-gaap:CostOfSalesMember 2022-12-31 0001863006 vln:PTKSponsorMember 2023-01-01 2023-06-30 0001863006 srt:MinimumMember 2023-01-01 2023-06-30 0001863006 srt:MaximumMember 2023-01-01 2023-06-30 0001863006 srt:MinimumMember 2022-01-01 2022-12-31 0001863006 srt:MaximumMember 2022-01-01 2022-12-31 0001863006 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001863006 us-gaap:FairValueInputsLevel3Member 2022-06-30 0001863006 us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-06-30 0001863006 us-gaap:FairValueInputsLevel3Member 2022-07-01 2022-12-31 0001863006 us-gaap:FairValueInputsLevel3Member 2023-06-30 0001863006 vln:ValensSemiconductorLtdTwoThousandTwentyOneShareIncentivePlanMember 2023-06-30 0001863006 vln:ValensSemiconductorLtdTwoThousandTwentyOneShareIncentivePlanMember 2022-12-31 0001863006 vln:MergerAndAcquisitionTransactionMember us-gaap:EmployeeStockOptionMember 2023-06-30 0001863006 vln:MergerAndAcquisitionTransactionMember us-gaap:EmployeeStockOptionMember 2023-01-01 2023-06-30 0001863006 us-gaap:RestrictedStockUnitsRSUMember 2023-06-30 0001863006 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-06-30 0001863006 us-gaap:RestrictedStockUnitsRSUMember vln:RelatedPartiesMember 2023-01-01 2023-06-30 0001863006 srt:MinimumMember vln:RangeOfExercisePriceOneMember 2023-01-01 2023-06-30 0001863006 srt:MaximumMember vln:RangeOfExercisePriceOneMember 2023-01-01 2023-06-30 0001863006 vln:RangeOfExercisePriceOneMember 2023-06-30 0001863006 vln:RangeOfExercisePriceOneMember 2023-01-01 2023-06-30 0001863006 vln:RangeOfExercisePriceTwoMember 2023-01-01 2023-06-30 0001863006 vln:RangeOfExercisePriceTwoMember 2023-06-30 0001863006 vln:RangeOfExercisePriceThreeMember 2023-01-01 2023-06-30 0001863006 vln:RangeOfExercisePriceThreeMember 2023-06-30 0001863006 vln:RangeOfExercisePriceFourMember 2023-01-01 2023-06-30 0001863006 vln:RangeOfExercisePriceFourMember 2023-06-30 0001863006 vln:RangeOfExercisePricesFiveMember 2023-01-01 2023-06-30 0001863006 vln:RangeOfExercisePricesFiveMember 2023-06-30 0001863006 vln:RangeOfExercisePricesSixMember 2023-01-01 2023-06-30 0001863006 vln:RangeOfExercisePricesSixMember 2023-06-30 0001863006 vln:RangeOfExercisePricesSevenMember 2023-01-01 2023-06-30 0001863006 vln:RangeOfExercisePricesSevenMember 2023-06-30 0001863006 vln:RangeOfExercisePricesEightMember 2023-01-01 2023-06-30 0001863006 vln:RangeOfExercisePricesEightMember 2023-06-30 0001863006 srt:MinimumMember 2022-01-01 2022-06-30 0001863006 srt:MaximumMember 2022-01-01 2022-06-30 0001863006 us-gaap:CostOfSalesMember 2023-01-01 2023-06-30 0001863006 us-gaap:CostOfSalesMember 2022-01-01 2022-06-30 0001863006 us-gaap:CostOfSalesMember 2023-04-01 2023-06-30 0001863006 us-gaap:CostOfSalesMember 2022-04-01 2022-06-30 0001863006 us-gaap:ResearchAndDevelopmentExpenseMember 2023-01-01 2023-06-30 0001863006 us-gaap:ResearchAndDevelopmentExpenseMember 2022-01-01 2022-06-30 0001863006 us-gaap:ResearchAndDevelopmentExpenseMember 2023-04-01 2023-06-30 0001863006 us-gaap:ResearchAndDevelopmentExpenseMember 2022-04-01 2022-06-30 0001863006 us-gaap:SellingAndMarketingExpenseMember 2023-01-01 2023-06-30 0001863006 us-gaap:SellingAndMarketingExpenseMember 2022-01-01 2022-06-30 0001863006 us-gaap:SellingAndMarketingExpenseMember 2023-04-01 2023-06-30 0001863006 us-gaap:SellingAndMarketingExpenseMember 2022-04-01 2022-06-30 0001863006 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-01-01 2023-06-30 0001863006 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-06-30 0001863006 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-04-01 2023-06-30 0001863006 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-04-01 2022-06-30 0001863006 us-gaap:RestrictedStockUnitsRSUMember 2023-07-01 2023-12-31 0001863006 us-gaap:RestrictedStockUnitsRSUMember 2023-12-31 0001863006 vln:TotalStockbasedCompensationRSUsMember 2023-01-01 2023-06-30 0001863006 vln:TotalStockbasedCompensationRSUsMember 2022-01-01 2022-06-30 0001863006 vln:TotalStockbasedCompensationRSUsMember 2023-04-01 2023-06-30 0001863006 vln:TotalStockbasedCompensationRSUsMember 2022-04-01 2022-06-30 0001863006 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-06-30 0001863006 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-06-30 0001863006 us-gaap:EmployeeStockOptionMember 2023-04-01 2023-06-30 0001863006 us-gaap:EmployeeStockOptionMember 2022-04-01 2022-06-30 0001863006 vln:RestrictedStockUnitsMember 2023-01-01 2023-06-30 0001863006 vln:RestrictedStockUnitsMember 2022-01-01 2022-06-30 0001863006 vln:RestrictedStockUnitsMember 2023-04-01 2023-06-30 0001863006 vln:RestrictedStockUnitsMember 2022-04-01 2022-06-30 0001863006 vln:PrivateWarrantMember 2023-01-01 2023-06-30 0001863006 vln:PrivateWarrantMember 2022-01-01 2022-06-30 0001863006 vln:PrivateWarrantMember 2023-04-01 2023-06-30 0001863006 vln:PrivateWarrantMember 2022-04-01 2022-06-30 0001863006 vln:PublicWarrantMember 2023-01-01 2023-06-30 0001863006 vln:PublicWarrantMember 2022-01-01 2022-06-30 0001863006 vln:PublicWarrantMember 2023-04-01 2023-06-30 0001863006 vln:PublicWarrantMember 2022-04-01 2022-06-30 0001863006 vln:ForfeiltureSharesMember 2023-01-01 2023-06-30 0001863006 vln:ForfeiltureSharesMember 2022-01-01 2022-06-30 0001863006 vln:ForfeiltureSharesMember 2023-04-01 2023-06-30 0001863006 vln:ForfeiltureSharesMember 2022-04-01 2022-06-30 0001863006 vln:AudioVideoMember 2023-01-01 2023-06-30 0001863006 vln:AutomotiveMember 2023-01-01 2023-06-30 0001863006 us-gaap:MaterialReconcilingItemsMember 2023-01-01 2023-06-30 0001863006 vln:AudioVideoMember 2022-01-01 2022-06-30 0001863006 vln:AutomotiveMember 2022-01-01 2022-06-30 0001863006 us-gaap:MaterialReconcilingItemsMember 2022-01-01 2022-06-30 0001863006 vln:AudioVideoMember 2023-04-01 2023-06-30 0001863006 vln:AutomotiveMember 2023-04-01 2023-06-30 0001863006 us-gaap:MaterialReconcilingItemsMember 2023-04-01 2023-06-30 0001863006 vln:AudioVideoMember 2022-04-01 2022-06-30 0001863006 vln:AutomotiveMember 2022-04-01 2022-06-30 0001863006 us-gaap:MaterialReconcilingItemsMember 2022-04-01 2022-06-30 0001863006 country:IL 2023-01-01 2023-06-30 0001863006 country:IL 2022-01-01 2022-06-30 0001863006 country:IL 2023-04-01 2023-06-30 0001863006 country:IL 2022-04-01 2022-06-30 0001863006 country:CN 2023-01-01 2023-06-30 0001863006 country:CN 2022-01-01 2022-06-30 0001863006 country:CN 2023-04-01 2023-06-30 0001863006 country:CN 2022-04-01 2022-06-30 0001863006 country:US 2023-01-01 2023-06-30 0001863006 country:US 2022-01-01 2022-06-30 0001863006 country:US 2023-04-01 2023-06-30 0001863006 country:US 2022-04-01 2022-06-30 0001863006 country:HK 2023-01-01 2023-06-30 0001863006 country:HK 2022-01-01 2022-06-30 0001863006 country:HK 2023-04-01 2023-06-30 0001863006 country:HK 2022-04-01 2022-06-30 0001863006 country:HU 2023-01-01 2023-06-30 0001863006 country:HU 2022-01-01 2022-06-30 0001863006 country:HU 2023-04-01 2023-06-30 0001863006 country:HU 2022-04-01 2022-06-30 0001863006 country:JP 2023-01-01 2023-06-30 0001863006 country:JP 2022-01-01 2022-06-30 0001863006 country:JP 2023-04-01 2023-06-30 0001863006 country:JP 2022-04-01 2022-06-30 0001863006 country:DE 2023-01-01 2023-06-30 0001863006 country:DE 2022-01-01 2022-06-30 0001863006 country:DE 2023-04-01 2023-06-30 0001863006 country:DE 2022-04-01 2022-06-30 0001863006 country:TW 2023-01-01 2023-06-30 0001863006 country:TW 2022-01-01 2022-06-30 0001863006 country:TW 2023-04-01 2023-06-30 0001863006 country:TW 2022-04-01 2022-06-30 0001863006 vln:OtherGeographicalAreasMember 2023-01-01 2023-06-30 0001863006 vln:OtherGeographicalAreasMember 2022-01-01 2022-06-30 0001863006 vln:OtherGeographicalAreasMember 2023-04-01 2023-06-30 0001863006 vln:OtherGeographicalAreasMember 2022-04-01 2022-06-30 0001863006 vln:CustomerAMember us-gaap:AccountsReceivableMember 2023-01-01 2023-06-30 0001863006 vln:CustomerAMember us-gaap:AccountsReceivableMember 2022-01-01 2022-12-31 0001863006 vln:CustomerBMember us-gaap:AccountsReceivableMember 2023-01-01 2023-06-30 0001863006 vln:CustomerBMember us-gaap:AccountsReceivableMember 2022-01-01 2022-12-31 0001863006 vln:CustomerCMember us-gaap:AccountsReceivableMember 2023-01-01 2023-06-30 0001863006 vln:CustomerCMember us-gaap:AccountsReceivableMember 2022-01-01 2022-12-31 0001863006 vln:CustomerAMember us-gaap:SalesRevenueNetMember 2023-01-01 2023-06-30 0001863006 vln:CustomerAMember us-gaap:SalesRevenueNetMember 2022-01-01 2022-06-30 0001863006 vln:CustomerAMember us-gaap:SalesRevenueNetMember 2023-04-01 2023-06-30 0001863006 vln:CustomerAMember us-gaap:SalesRevenueNetMember 2022-04-01 2022-06-30 0001863006 vln:CustomerBMember us-gaap:SalesRevenueNetMember 2023-01-01 2023-06-30 0001863006 vln:CustomerBMember us-gaap:SalesRevenueNetMember 2022-01-01 2022-06-30 0001863006 vln:CustomerBMember us-gaap:SalesRevenueNetMember 2023-04-01 2023-06-30 0001863006 vln:CustomerBMember us-gaap:SalesRevenueNetMember 2022-04-01 2022-06-30 0001863006 vln:CustomerDMember us-gaap:SalesRevenueNetMember 2023-01-01 2023-06-30 0001863006 vln:CustomerDMember us-gaap:SalesRevenueNetMember 2022-01-01 2022-06-30 0001863006 vln:CustomerDMember us-gaap:SalesRevenueNetMember 2023-04-01 2023-06-30 0001863006 vln:CustomerDMember us-gaap:SalesRevenueNetMember 2022-04-01 2022-06-30 0001863006 vln:CustomerEMember us-gaap:SalesRevenueNetMember 2023-01-01 2023-06-30 0001863006 vln:CustomerEMember us-gaap:SalesRevenueNetMember 2022-01-01 2022-06-30 0001863006 vln:CustomerEMember us-gaap:SalesRevenueNetMember 2023-04-01 2023-06-30 0001863006 vln:CustomerEMember us-gaap:SalesRevenueNetMember 2022-04-01 2022-06-30 0001863006 country:IL 2023-06-30 0001863006 country:IL 2022-12-31 0001863006 country:TW 2023-06-30 0001863006 country:TW 2022-12-31 0001863006 country:CN 2023-06-30 0001863006 country:CN 2022-12-31 0001863006 country:US 2023-06-30 0001863006 country:US 2022-12-31 0001863006 country:SG 2023-06-30 0001863006 country:SG 2022-12-31 0001863006 vln:OtherGeographicalAreasMember 2023-06-30 0001863006 vln:OtherGeographicalAreasMember 2022-12-31 iso4217:USD iso4217:USD xbrli:shares xbrli:shares xbrli:pure